PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.49
+3.52 (1.55%)
AAPL  269.07
+0.26 (0.10%)
AMD  260.14
+0.47 (0.18%)
BAC  52.72
-0.30 (-0.58%)
GOOG  268.68
-1.25 (-0.46%)
META  755.28
+4.46 (0.59%)
MSFT  542.23
+10.71 (2.02%)
NVDA  197.94
+6.45 (3.37%)
ORCL  284.55
+3.15 (1.12%)
TSLA  459.70
+7.28 (1.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.